当前位置：首页 SCI期刊 SCIE期刊医学中科院4区 JCRQ2 期刊介绍(非官网)

Human Vaccines & ImmunotherapeuticsSCIE

国际简称：HUM VACC IMMUNOTHER 参考译名：人类疫苗和免疫疗法

中科院分区
4区
CiteScore分区
Q1
JCR分区
Q2

基本信息：: ISSN：2164-5515; E-ISSN：2164-554X; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：UNITED STATES; 出版商：Landes Bioscience; 出版语言：English; 出版周期：Monthly; 出版年份：2005; 研究方向：BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

评价信息：: 影响因子：4.1; H-index：43; CiteScore指数：7.9; SJR指数：0.927; SNIP指数：0.897

发文数据：: Gold OA文章占比：80.48%; 研究类文章占比：80.75%; 年发文量：452; 自引率：0.0833...; 开源占比：0.5687; 出版撤稿占比：0; 出版国人文章占比：0.13; OA被引用占比：0.2287...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Human Vaccines & Immunotherapeutics期刊介绍

(formerly Human Vaccines; issn 1554-8619)

Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.

Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.

期刊简介Human Vaccines & Immunotherapeutics期刊介绍

《Human Vaccines & Immunotherapeutics》自2005出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：一般,3-6周
医学
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
SCIE
中科院4区
非预警

Cite Score数据（2024年最新版）Human Vaccines & Immunotherapeutics Cite Score数据

CiteScore：7.9
SJR：0.927
SNIP：0.897

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q1	71 / 313	77%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Immunology and Allergy	Q2	69 / 233	70%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Immunology	Q2	81 / 236	65%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Human Vaccines & Immunotherapeutics 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	4区	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 IMMUNOLOGY 免疫学	3区 4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Human Vaccines & Immunotherapeutics JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q2	45 / 174	74.4%
学科：IMMUNOLOGY	SCIE	Q2	74 / 181	59.4%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q2	53 / 174	69.83%
学科：IMMUNOLOGY	SCIE	Q2	57 / 181	68.78%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
USA479
CHINA MAINLAND267
Italy117
England97
Belgium86
Canada82
France70
Australia69
India67
Japan55

本刊中国学者近年发表论文

1、A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients
Author: Chen, Sikai; Wei, Wenxin; Huang, Fengyu; Wang, Jing; Li, Xingyu; Gen, Zhixin; Gao, Feng; Dong, Taiwei; Wei, Peifeng; Yang, Xinbo; Miao, Feng

Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/21645515.2023.2196893
2、Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
Author: Sun, Dapeng; Yu, Dan; Du, Zhenhua; Jia, Ningning; Liu, Xiaodong; Sun, Jianwen; Xu, Qing; Sun, Zhuoqun; Luan, Chunfang; Lv, Jingjing; Xiong, Ping; Zhang, Li; Sha, Xueyan; Gao, Yongjun; Kang, Dianmin

Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2022.2161789
3、Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China
Author: Yin, Zhiying; Fang, Quanjun; Wen, Tingcui; Zheng, Canjie; Fu, Canya; Wang, Shuangqing; Li, Junji; Gong, Xiaoying

Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/21645515.2022.2163813
4、Establishment of the 1st Chinese national standard for CA6 neutralizing antibody
Author: Wang, Yiping; Gao, Fan; Liang, Zhenglun; Sun, Huimin; Wang, Junzhi; Mao, Qunying

Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2022.2164140
5、Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China
Author: Shao, Hui; Lin, Xiao-Qing; Chen, Yan; Lv, Li; Ying, Chen-Qian; Tung, Tao-Hsin; Zhu, Jian-Sheng

Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2022.2158012
6、Gap between cognitions and behaviors among children's guardians of influenza vaccination: The role of social influence and vaccine-related knowledge
Author: Wu, Jing; Wei, Zheng; Yang, Yingying; Sun, Xiu; Zhan, Siyi; Jiang, Qijing; Fu, Chuanxi

Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2023.2166285
7、Mumps-specific antibody persistence in children aged 3-7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China
Author: Sun, Jinfang; Li, Mingma; Zhang, Lei; Deng, Xiuying; Hu, Ying; Chen, Qiang; Wang, Zhiguo; Sun, Xiang; Liu, Yuanbao

Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. 19, Issue 1, pp. -. DOI: 10.1080/21645515.2023.2166758
8、COVID-19 vaccine uptake, reasons, and associated factors among older adults in Shenzhen, China
Author: Xie, Pei; Shi, XiuYuan; Zhu, Bin; Zhao, Wenjing; Li, Xiaoheng; Zou, Xuan; Liu, Gang; Han, Xinxin

Journal: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/21645515.2023.2196914